Histoplathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels

被引:93
作者
Cusick, M
Chew, EY
Chan, CC
Kruth, HS
Murphy, RP
Ferris, FL
机构
[1] NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA
[2] Howard Hughes Med Inst, NIH, Res Scholars Program, Bethesda, MD USA
[3] NEI, Immunol Lab, NIH, Bethesda, MD 20892 USA
[4] Natl Heart Lung & Blood Inst, Sect Expt Atherosclerosis, NIH, Bethesda, MD USA
[5] Retina Grp Washington, Fairfax, VA USA
关键词
D O I
10.1016/j.ophtha.2003.01.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe a regression of retinal hard exudates in 2 patients with diabetic maculopathy, and to report immunohistologic findings reflecting lipid deposition in the retina. Design: Two interventional case reports. Methods: Two patients with exudative diabetic maculopathy were treated to normalize serum lipids. Histologic examination and immunohistochemistry of each patient's eyes were performed to assess the localization of apolipoprotein B and cholesteryl ester, both of which are principal components of low-density lipoprotein. Results: Both patients showed a dramatic regression of retinal hard exudates after correction of dyslipidemia. Histopathology revealed diffuse lipids and cholesteryl ester in the retina. Apolipoprotein B and macrophages were colocalized in the perivascular space. Conclusions: The regression of hard exudates was most likely due to the aggressive lipid lowering in both patients. The novel histopathologic findings of hard exudate and diabetic maculopathy are similar to the pathologic changes observed in larger atherosclerotic lesions, except that they occur in the intraretinal perivascular space. (C) 2003 by the American Academy of Ophthalmology.
引用
收藏
页码:2126 / 2133
页数:8
相关论文
共 32 条
[1]  
American Diabetes Association, 2002, DIABETES CARE, V25, pS74, DOI DOI 10.2337/DIACARE.25.2007.S74
[2]  
[Anonymous], 1991, Ophthalmology, V98, P786
[3]  
[Anonymous], 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI [DOI 10.1001/ARCHOPHT.1985.01050120030015, 10.1001/archopht.1985.01050120030015]
[4]  
CHAN CC, 1985, OPHTHALMOLOGY, V92, P580
[5]   Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy - Early treatment diabetic retinopathy study (ETDRS) report 22 [J].
Chew, EY ;
Klein, ML ;
Ferris, FL ;
Remaley, NA ;
Murphy, RP ;
Chantry, K ;
Hoogwerf, BJ ;
Miller, D .
ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (09) :1079-1084
[6]   Mechanisms of diabetic vasculopathy: An overview [J].
Cooper, ME ;
Bonnet, F ;
Oldfield, M ;
Jandeleit-Dahm, K .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (05) :475-486
[7]   Lipid lowering by simvastatin induces regression of human atherosclerotic lesions - Two years' follow-up by high-resolution noninvasive magnetic resonance imaging [J].
Corti, R ;
Fuster, V ;
Fayad, ZA ;
Worthley, SG ;
Helft, G ;
Smith, D ;
Weinberger, J ;
Wentzel, J ;
Mizsei, G ;
Mercuri, M ;
Badimon, JJ .
CIRCULATION, 2002, 106 (23) :2884-2887
[8]   RAPID TIGHTENING OF BLOOD-GLUCOSE CONTROL LEADS TO TRANSIENT DETERIORATION OF RETINOPATHY IN INSULIN DEPENDENT DIABETES-MELLITUS - THE OSLO STUDY [J].
DAHLJORGENSEN, K ;
BRINCHMANNHANSEN, O ;
HANSSEN, KF ;
SANDVIK, L ;
AAGENAES, O .
BRITISH MEDICAL JOURNAL, 1985, 290 (6471) :811-815
[9]   A 3-YEAR TRIAL OF ATROMID THERAPY IN EXUDATIVE DIABETIC RETINOPATHY [J].
DUNCAN, LJP ;
CULLEN, JF ;
IRELAND, JT ;
NOLAN, J ;
CLARKE, BF ;
OLIVER, MF .
DIABETES, 1968, 17 (07) :458-&
[10]  
*EARL TREATM DIAB, 1991, OPHTHALMOLOGY S, V98, P767